13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001193125-25-283094
Total Value
$1.51B
Positions
21
Other Managers
12
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HEARTFLOW INC | HTFL | 12,448,158 | $419.0M | 27.81% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,719,110 | $304.9M | 20.23% |
| 3 | CIDARA THERAPEUTICS INC | 171757206 | 3,020,990 | $289.3M | 19.20% |
| 4 | PHARVARIS N V | PHVS | 3,181,275 | $79.4M | 5.27% |
| 5 | OLEMA PHARMACEUTICALS INC | OLMA | 6,843,954 | $67.0M | 4.45% |
| 6 | SAVARA INC | SVRA | 17,600,621 | $62.8M | 4.17% |
| 7 | DIANTHUS THERAPEUTICS INC | DNTH | 1,315,892 | $51.8M | 3.44% |
| 8 | SOLID BIOSCIENCES INC | SLDB | 7,911,669 | $48.8M | 3.24% |
| 9 | UPSTREAM BIO INC | UPB | 2,439,538 | $45.9M | 3.05% |
| 10 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $28.2M | 1.87% |
| 11 | TANGO THERAPEUTICS INC | TNGX | 2,712,008 | $22.8M | 1.51% |
| 12 | CABALETTA BIO INC | CABA | 9,677,125 | $22.6M | 1.50% |
| 13 | KYVERNA THERAPEUTICS INC | KYTX | 3,368,370 | $20.2M | 1.34% |
| 14 | ANNEXON INC | ANNX | 5,249,069 | $16.0M | 1.06% |
| 15 | X4 PHARMACEUTICALS INC | XFOR | 2,436,588 | $8.3M | 0.55% |
| 16 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $7.2M | 0.48% |
| 17 | XILIO THERAPEUTICS INC | XLO | 4,566,817 | $3.8M | 0.26% |
| 18 | MERSANA THERAPEUTICS INC | 59045L205 | 346,545 | $2.7M | 0.18% |
| 19 | C4 THERAPEUTICS INC | CCCC | 1,111,910 | $2.5M | 0.16% |
| 20 | CENTURY THERAPEUTICS INC | IPSC | 3,538,609 | $1.8M | 0.12% |
| 21 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $1.7M | 0.11% |